[go: up one dir, main page]

CN102603660B - Preparation method of 1H-1,2,3-triazole compound - Google Patents

Preparation method of 1H-1,2,3-triazole compound Download PDF

Info

Publication number
CN102603660B
CN102603660B CN201210029408.2A CN201210029408A CN102603660B CN 102603660 B CN102603660 B CN 102603660B CN 201210029408 A CN201210029408 A CN 201210029408A CN 102603660 B CN102603660 B CN 102603660B
Authority
CN
China
Prior art keywords
preparation
reaction
formula
triazole class
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210029408.2A
Other languages
Chinese (zh)
Other versions
CN102603660A (en
Inventor
崔冬梅
陈颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pingyi Ren'an Traditional Chinese Medicine Industry Development Co ltd
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN201210029408.2A priority Critical patent/CN102603660B/en
Publication of CN102603660A publication Critical patent/CN102603660A/en
Application granted granted Critical
Publication of CN102603660B publication Critical patent/CN102603660B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

本发明公开了一种式(I)所示的1H-1,2,3-三唑类化合物的制备方法,所述的制备方法为:将式(III)所示的卤代物与式(II)所示的端基炔类化合物以及叠氮化钠混合,于反应溶剂中在多孔铜的催化作用下于25~80℃反应5~85h,反应结束后,反应液后处理制得式(I)所示的1H-1,2,3-三唑类化合物;所述的溶剂为去离子水、乙腈、无水乙醇、甲苯、丙酮、N,N-二甲基甲酰胺、四氢呋喃或二氧六环。本发明采用一锅法操作,催化剂可多次重复利用,条件温和,操作简便。 The invention discloses a preparation method of 1H-1,2,3-triazole compounds represented by formula (I). The preparation method is: combining the halogenated compound represented by formula (III) with the formula (II ) shown in the end group alkyne compound and sodium azide mixed, in the reaction solvent under the catalysis of porous copper at 25 ~ 80 ℃ for 5 ~ 85h, after the reaction, the reaction solution post-treatment to prepare the formula (I ) represented by 1H-1,2,3-triazole compounds; the solvent is deionized water, acetonitrile, absolute ethanol, toluene, acetone, N,N-dimethylformamide, tetrahydrofuran or dioxygen six rings. The invention adopts one-pot operation, the catalyst can be reused many times, the condition is mild, and the operation is simple and convenient.

Description

一种1H-1,2,3-三唑类化合物的制备方法A kind of preparation method of 1H-1,2,3-triazole compound

(一)技术领域 (1) Technical field

本发明涉及一种1H-1,2,3-三唑化合物的制备方法。  The invention relates to a preparation method of 1H-1,2,3-triazole compound. the

(二)背景技术 (2) Background technology

1H-1,2,3-三唑类化合物作为重要化工原料中间体,被广泛应用于农药、医药等合成领域。关于1H-1,2,3-三唑类化合物的合成方法到目前为止报道较少:1.通过聚苯乙烯磺酰肼与1,1-二氯丙酮作用,得到α-二氯羰基磺酰腙,再与胺经环化作用制备(Makam S.Raghavendra and Yulin Lam,Tetrahedron Letters,2004,45,6129-6132)。2.通过铜催化炔/叠氮化物进行1,3-偶极环加成(CuACC)的click反应进行制备(Christian W. 

Figure BDA0000134951280000011
Caspar Christensen,and Morten Melda.J.Org.Chem,2002,67,3057-3064)。3.以苯胺为原料,通过铜(II)催化重氮基的转移,然后在抗坏血酸钠的还原作用下,得到的铜(I)催化炔/叠氮的1,3-偶极环加成(Henning S.G.Beckmann and Valentin Wittmann.Org.Lett.2007,9(1),1-4)。但上述制备方法仍存在很多缺陷:如催化剂昂贵、难以得到,容易生成副产物,收率不高,适用范围不广,局限性较大,条件苛刻,因此限制了其应用性。  1H-1,2,3-triazole compounds, as important chemical raw material intermediates, are widely used in the synthesis fields of pesticides and medicines. About the synthetic method of 1H-1,2,3-triazole compounds so far reported less: 1. by polystyrene sulfonyl hydrazide and 1,1-dichloroacetone, obtain α-dichlorocarbonylsulfonyl Hydrazone, and then prepared by cyclization with amine (Makam S. Raghavendra and Yulin Lam, Tetrahedron Letters, 2004, 45, 6129-6132). 2. Preparation via copper-catalyzed 1,3-dipolar cycloaddition (CuACC) click reaction of alkynes/azides (Christian W.
Figure BDA0000134951280000011
Caspar Christensen, and Morten Melda. J. Org. Chem, 2002, 67, 3057-3064). 3. With aniline as raw material, the transfer of diazo group is catalyzed by copper (II), and then under the reduction of sodium ascorbate, the copper (I) obtained catalyzes the 1,3-dipolar cycloaddition of alkyne/azide ( Henning SG Beckmann and Valentin Wittmann. Org. Lett. 2007, 9(1), 1-4). However, the above-mentioned preparation method still has many defects: such as expensive catalyst, difficult to obtain, easy to generate by-products, low yield, limited scope of application, large limitations, and harsh conditions, thus limiting its applicability.

(三)发明内容 (3) Contents of the invention

本发明目的是改进现有技术的各种缺陷,提供一种催化剂易得可多次重复利用、条件温和、操作简便的一锅法制备1H-1,2,3-三唑类化合物的方法。  The purpose of the present invention is to improve various defects of the prior art, and to provide a one-pot method for preparing 1H-1,2,3-triazole compounds with easy-to-obtain catalyst, repeated use, mild conditions and easy operation. the

为实现上述发明目的,本发明采用的技术方案是:  For realizing above-mentioned purpose of the invention, the technical scheme that the present invention adopts is:

一种式(I)所示的1H-1,2,3-三唑类化合物的制备方法,所述的制备方法为:将式(III)所示的卤代物与式(II)所示的端基炔类化合物以及叠氮化钠混合,于反应溶剂中在多孔铜的催化作用下于25~80℃反应5~85h,反应结束后,反应液后处理制得式(I)所示的1H-1,2,3-三唑类 化合物;所述的反应溶剂为去离子水、乙腈、无水乙醇、甲苯、丙酮、N,N-二甲基甲酰胺、四氢呋喃或二氧六环;  A preparation method of 1H-1,2,3-triazole compounds shown in formula (I), the preparation method is: the halogenated compound shown in formula (III) and the compound shown in formula (II) The terminal alkyne compound and sodium azide are mixed, and reacted in a reaction solvent at 25-80° C. for 5-85 hours under the catalysis of porous copper. After the reaction is completed, the reaction solution is post-treated to obtain the compound shown in formula (I). 1H-1,2,3-triazole compounds; the reaction solvent is deionized water, acetonitrile, absolute ethanol, toluene, acetone, N,N-dimethylformamide, tetrahydrofuran or dioxane;

Figure BDA0000134951280000021
Figure BDA0000134951280000021

式(I)、式(II)或式(III)中,X为卤素、OAc、OMs(甲磺酸基)或OTf(三氟甲磺酸基);R1为C1至C13烷基、苄基、取代苄基或乙酸乙酯基,所述取代苄基苯环上的取代基为单取代卤素或单取代C1至C5烷基;R2为C6至C13烷基、5元至9元环烯基、苯基、取代苯基、邻苯二甲酰亚胺甲基或吡啶基,所述取代苯基的取代基为单取代C1至C5烷氧基或单取代卤素。  In formula (I), formula (II) or formula (III), X is halogen, OAc, OMs (mesylate) or OTf (trifluoromethanesulfonate); R 1 is C1 to C13 alkyl, benzyl group, substituted benzyl or ethyl acetate group, the substituent on the substituted benzyl benzene ring is monosubstituted halogen or monosubstituted C1 to C5 alkyl; R2 is C6 to C13 alkyl, 5 to 9 membered ring Alkenyl, phenyl, substituted phenyl, phthalimide methyl or pyridyl, the substituent of the substituted phenyl is monosubstituted C1 to C5 alkoxy or monosubstituted halogen.

进一步,X优选为Br、Cl或I。  Further, X is preferably Br, Cl or I. the

进一步,R1优选为苄基、C1至C8烷基或乙酸乙酯基。更进一步,所述的C1至C8的烷基优选乙基或丁基。  Further, R 1 is preferably benzyl, C1 to C8 alkyl or ethyl acetate. Furthermore, the C1 to C8 alkyl group is preferably ethyl or butyl.

进一步,R2优选为苯基、对甲氧基苯基、对乙氧基苯基、对氯苯基、间氟苯基、4-吡啶基、1-环己烯基、邻苯二甲酰亚胺甲基或C6至C10烷基。更进一步,所述C6至C10烷基优选辛基。  Further, R is preferably phenyl, p-methoxyphenyl, p-ethoxyphenyl, p-chlorophenyl, m-fluorophenyl, 4-pyridyl, 1-cyclohexenyl, phthaloyl iminomethyl or C6 to C10 alkyl. Further, the C6 to C10 alkyl group is preferably an octyl group.

具体的,本发明优选式(II)所示的端基炔类化合物为苯乙炔、4-甲氧基苯乙炔、4-乙氧基苯乙炔、4-氯苯乙炔、3-氟苯乙炔、1-邻苯二甲酰亚胺丙炔、4-吡碇乙炔、1-环己烯基乙炔或1-辛炔。  Concretely, the preferred terminal group alkynes represented by formula (II) in the present invention are phenylacetylene, 4-methoxyphenylacetylene, 4-ethoxyphenylacetylene, 4-chlorophenylacetylene, 3-fluorophenylacetylene, 1-phthalimidepropyne, 4-pyridineacetylene, 1-cyclohexenylacetylene or 1-octyne. the

具体的,本发明优选式(III)所示的卤代物为苄溴、苄氯、碘乙烷、溴代正丁烷或1-溴乙酸乙酯。  Specifically, the preferred halide represented by formula (III) in the present invention is benzyl bromide, benzyl chloride, ethyl iodide, n-bromobutane or ethyl 1-bromoacetate. the

本发明中,所述的反应溶剂优选为去离子水,具有绿色环保、成本低、反应收率高的优势。  In the present invention, the reaction solvent is preferably deionized water, which has the advantages of environmental protection, low cost and high reaction yield. the

本发明中,所述的催化剂为多孔铜,孔径优选为5~150μm,更优选为5~50μm,更进一 步优选为5~20μm,最优选为5μm。本发明中多孔铜使用市售商品。  In the present invention, the catalyst is porous copper, and the pore diameter is preferably 5-150 μm, more preferably 5-50 μm, even more preferably 5-20 μm, most preferably 5 μm. In the present invention, a commercially available item is used for the porous copper. the

本发明中,所述的卤代物(III)与端基炔类化合物(II)、叠氮化钠、铜催化剂的投料物质的量之比为1∶1.0~1.2∶1.2~2∶0.05~0.15,最优选为1∶1.1∶2∶0.05。  In the present invention, the ratio of the amount of the halogenated compound (III) to the terminal alkyne compound (II), sodium azide, copper catalyst is 1: 1.0~1.2: 1.2~2: 0.05~0.15 , most preferably 1:1.1:2:0.05. the

本发明中,所述反应溶剂的体积用量以卤代物(III)的摩尔数计为4~10ml/mmol,最优选为4ml/mmol。  In the present invention, the volumetric amount of the reaction solvent is 4-10 ml/mmol, most preferably 4 ml/mmol, based on the number of moles of the halide (III). the

本发明反应条件温和,优选反应温度在55~60℃,优选反应时间为8~50h。  The reaction conditions of the present invention are mild, preferably the reaction temperature is 55-60° C., and the preferred reaction time is 8-50 h. the

本发明在反应结束后,所得反应液经常规后处理即可获得目标产物。本发明推荐所述的后处理方法为:反应结束后,所得反应液用乙酸乙酯萃取,饱和氯化钠洗涤,有机相干燥,浓缩,然后以体积比为5∶1的石油醚和乙酸乙酯作为展开剂,进行柱层析,收集Rf值0.3~0.35的洗脱液,减压蒸馏,干燥,获得1H-1,2,3-三唑类化合物。  In the present invention, after the reaction is completed, the obtained reaction liquid can be subjected to conventional aftertreatment to obtain the target product. The post-treatment method recommended by the present invention is as follows: after the reaction is finished, the resulting reaction solution is extracted with ethyl acetate, washed with saturated sodium chloride, dried and concentrated, and then mixed with petroleum ether and ethyl acetate at a volume ratio of 5:1. The ester is used as a developing agent, and the column chromatography is carried out, and the eluate with an Rf value of 0.3-0.35 is collected, distilled under reduced pressure, and dried to obtain 1H-1,2,3-triazole compounds.

本发明具体推荐所述的1H-1,2,3-三唑类化合物的制备方法按照以下步骤进行:将式(III)所示的卤代物与式(II)所示的端基炔类化合物以及叠氮化钠混合,于去离子水中在多孔铜的催化作用下于55℃~60℃反应8~50h,反应结束后,所得反应液用乙酸乙酯萃取,饱和氯化钠洗涤,有机相干燥,浓缩,然后以体积比为5∶1的石油醚和乙酸乙酯作为展开剂,进行柱层析,收集Rf值0.3~0.35的洗脱液,减压蒸馏,干燥,获得(I)所示的1H-1,2,3-三唑类化合物;所述的卤代物(III)与端基炔类化合物(II)、叠氮化钠、多孔铜的投料物质的量之比为1∶1.1∶2∶0.05;所述的去离子水的体积用量以卤代物(III)的摩尔数计为4ml/mmol。  The present invention specifically recommends that the preparation method of the described 1H-1,2,3-triazole compound is carried out according to the following steps: the halogenated compound shown in formula (III) and the terminal alkyne compound shown in formula (II) Mix with sodium azide, react in deionized water under the catalysis of porous copper at 55°C-60°C for 8-50h, after the reaction, the obtained reaction solution is extracted with ethyl acetate, washed with saturated sodium chloride, and the organic phase Drying, concentrating, and then using sherwood oil and ethyl acetate with a volume ratio of 5:1 as a developing solvent, carrying out column chromatography, collecting the eluent with an Rf value of 0.3 to 0.35, distilling under reduced pressure, and drying to obtain (I) Shown 1H-1,2,3-triazole compound; The ratio of the amount of the feed material of the halogenated compound (III) to the end group alkyne compound (II), sodium azide, porous copper is 1 : 1.1: 2: 0.05; the volumetric dosage of the deionized water is 4ml/mmol based on the moles of halide (III).

与现有技术相比,本发明提供的1H-1,2,3-三唑类化合物的制备方法的优点在于:  Compared with the prior art, the advantages of the preparation method of 1H-1,2,3-triazole compounds provided by the invention are:

(1)本发明采用了一锅法方法制备1H-1,2,3-三唑类化合物,反应条件温和,操作方便。  (1) The present invention adopts a one-pot method to prepare 1H-1,2,3-triazole compounds with mild reaction conditions and convenient operation. the

(2)本发明选用了便宜易得的多孔铜作为催化剂,并且该催化剂不需要处理就可以重复利用多次,符合原子经济原则;同时本发明选用了去离子水作为溶剂,对环境友好,成本低,反应收率高,产品质量好。  (2) The present invention has selected cheap and easy-to-get porous copper as the catalyst, and the catalyst can be reused many times without treatment, which meets the principle of atom economy; simultaneously, the present invention has selected deionized water as the solvent, which is environmentally friendly and low cost Low, high reaction yield, good product quality. the

鉴于1H-1,2,3-三唑类化合物具有较强的生物活性,如具有抗过敏、抗菌、抗HIV活性,因此在药物设计中得到广泛的应用,因此本发明有着广泛的工业应用前景。  In view of the fact that 1H-1,2,3-triazole compounds have strong biological activities, such as anti-allergic, antibacterial, and anti-HIV activities, they are widely used in drug design, so the present invention has a wide range of industrial application prospects . the

(四)具体实施方式 (4) Specific implementation methods

下面将通过实施例对本发明作进一步的说明,但本发明的保护范围不限于此。  The present invention will be further described below through examples, but the protection scope of the present invention is not limited thereto. the

本发明实施例使用的多孔铜由长沙力元新材料有限责任公司生产。  The porous copper used in the embodiment of the present invention is produced by Changsha Liyuan New Material Co., Ltd. the

实施例1:式(I-1)所示的1-苄基-4-苯基-1,2,3-三唑的制备  Embodiment 1: the preparation of 1-benzyl-4-phenyl-1,2,3-triazole shown in formula (I-1)

Figure BDA0000134951280000041
Figure BDA0000134951280000041

将式(III-1)所示的苄溴(171.0mg,1mmol),叠氮化钠(130mg,2mmol),式(II-1)所示的苯乙炔(112.3mg,1.1mmol),多孔铜(5μm孔径,3.2mg,0.05mmol)在去离子水(4ml)中混合,55℃油浴中搅拌反应29h,TLC跟踪反应。反应结束后,用乙酸乙酯(10mL×3)萃取,饱和食盐水洗涤,合并有机相,无水硫酸钠干燥,过滤,浓缩,柱层析(石油醚∶乙酸乙酯=5∶1),收集Rf值0.3~0.35的洗脱液,减压蒸馏,干燥得到目标化合物224.6mg,收率为95.47%,白色针状晶体。  Benzyl bromide (171.0mg, 1mmol) shown in formula (III-1), sodium azide (130mg, 2mmol), phenylacetylene (112.3mg, 1.1mmol) shown in formula (II-1), porous copper (5 μm pore size, 3.2 mg, 0.05 mmol) were mixed in deionized water (4 ml), stirred and reacted in an oil bath at 55° C. for 29 h, followed by TLC. After the reaction, extract with ethyl acetate (10mL×3), wash with saturated brine, combine the organic phases, dry over anhydrous sodium sulfate, filter, concentrate, column chromatography (petroleum ether:ethyl acetate=5:1), The eluate with R f value of 0.3-0.35 was collected, distilled under reduced pressure, and dried to obtain 224.6 mg of the target compound, with a yield of 95.47%, as white needle-like crystals.

1HNMR(CDCl3):δ=7.81-7.83(m,2H),7.68(s,1H),7.39-7.43(m,5H),7.32-7.34(m,3H),5.59(s,2H)  1 HNMR (CDCl 3 ): δ=7.81-7.83 (m, 2H), 7.68 (s, 1H), 7.39-7.43 (m, 5H), 7.32-7.34 (m, 3H), 5.59 (s, 2H)

实施例2:  Example 2:

将多孔铜的量增加到6.4mg(0.10mmol),反应时间为10小时,其他操作同实施例1,收率为94.9%。  The amount of porous copper was increased to 6.4mg (0.10mmol), the reaction time was 10 hours, other operations were the same as in Example 1, and the yield was 94.9%. the

实施例3:  Example 3:

将多孔铜的量增加到9.6mg(0.15mmol),反应时间为29小时,其他操作同实施例1,收率为94.81%。  The amount of porous copper was increased to 9.6mg (0.15mmol), the reaction time was 29 hours, other operations were the same as in Example 1, and the yield was 94.81%. the

实施例4:  Example 4:

将多孔铜的量增加到12.8mg(0.20mmol),反应时间为27.5小时,其他操作同实施例1,收率为94.25%。  The amount of porous copper was increased to 12.8 mg (0.20 mmol), the reaction time was 27.5 hours, other operations were the same as in Example 1, and the yield was 94.25%. the

实施例5:  Embodiment 5:

将多孔铜(5μm)改为多孔铜(20μm),反应时间为28小时,其他操作同实施例1,收率为87.20%。  Porous copper (5 μm) was changed to porous copper (20 μm), the reaction time was 28 hours, other operations were the same as in Example 1, and the yield was 87.20%. the

实施例6:  Embodiment 6:

将多孔铜(5μm)改为多孔铜(50μm),反应时间为43.5小时,其他操作同实施例1,收率为65.76%。  Porous copper (5 μm) was changed to porous copper (50 μm), the reaction time was 43.5 hours, other operations were the same as in Example 1, and the yield was 65.76%. the

实施例7:  Embodiment 7:

将多孔铜(5μm)改为多孔铜(150μm),反应时间为85小时,其他操作同实施例1,收率为27.30%。  Porous copper (5 μm) was changed to porous copper (150 μm), the reaction time was 85 hours, other operations were the same as in Example 1, and the yield was 27.30%. the

实施例8:  Embodiment 8:

将反应温度提高到80℃,反应时间为11小时,其他操作同实施例1,收率为94.99%。  The reaction temperature was increased to 80° C., the reaction time was 11 hours, other operations were the same as in Example 1, and the yield was 94.99%. the

实施例9:  Embodiment 9:

将溶剂去离子水换成乙腈,反应时间为22.5小时,其他操作同实施例1,收率为10.20%。  The solvent deionized water was replaced with acetonitrile, the reaction time was 22.5 hours, other operations were the same as in Example 1, and the yield was 10.20%. the

实施例10:  Embodiment 10:

将溶剂去离子水换成无水乙醇,反应时间为34小时,其他操作同实施例1,收率为44.17%。  The solvent deionized water was replaced with absolute ethanol, the reaction time was 34 hours, other operations were the same as in Example 1, and the yield was 44.17%. the

实施例11:  Example 11:

将溶剂去离子水换成甲苯,反应时间为28.5小时,其他操作同实施例1,收率为微量。  The solvent deionized water was replaced with toluene, and the reaction time was 28.5 hours. Other operations were the same as in Example 1, and the yield was a small amount. the

实施例12:  Example 12:

将溶剂去离子水换成丙酮,反应时间为24.5小时,其他操作同实施例1,收率为58.78%。  The solvent deionized water was replaced with acetone, and the reaction time was 24.5 hours. Other operations were the same as in Example 1, and the yield was 58.78%. the

实施例13:  Example 13:

将溶剂去离子水换成N,N-二甲基甲酰胺,反应时间为52.5小时,其他操作同实施例1,收率为28.10%。  The solvent deionized water was replaced with N,N-dimethylformamide, the reaction time was 52.5 hours, other operations were the same as in Example 1, and the yield was 28.10%. the

实施例14:  Example 14:

将溶剂去离子水换成四氢呋喃,反应时间为54.5小时,其他操作同实施例1,收率为4.50%。  The solvent deionized water was replaced with tetrahydrofuran, and the reaction time was 54.5 hours. Other operations were the same as in Example 1, and the yield was 4.50%. the

实施例15:  Example 15:

将溶剂去离子水换成二氧六环,反应时间为69小时,其他操作同实施例1,收率为5.30%。  The solvent deionized water was replaced with dioxane, and the reaction time was 69 hours. Other operations were the same as in Example 1, and the yield was 5.30%. the

实施例16:式(I-2)所示的1-苄基-4-对甲氧基苯基-1,2,3-三唑的制备  Embodiment 16: Preparation of 1-benzyl-4-p-methoxyphenyl-1,2,3-triazole shown in formula (I-2)

Figure BDA0000134951280000061
Figure BDA0000134951280000061

用145.4mg(1.1mmol)4-甲氧基苯乙炔(II-2)替代苯乙炔,其他操作同实施例1,得到目标产物(I-2)257.9mg,收率为97.2%,白色固体。  145.4 mg (1.1 mmol) of 4-methoxyphenylacetylene (II-2) was used instead of phenylacetylene, and the other operations were the same as in Example 1 to obtain 257.9 mg of the target product (I-2), with a yield of 97.2%, as a white solid. the

1HNMR(CDCl3):δ=7.74(d,J=8.5Hz,2H),7.59(s,1H),7.39-7.41(m,3H),7.32-7.34(m,2H),6.95(d,J=8.5Hz,2H),5.58(s,2H),3.85(m,3H)  1 HNMR (CDCl 3 ): δ=7.74(d, J=8.5Hz, 2H), 7.59(s, 1H), 7.39-7.41(m, 3H), 7.32-7.34(m, 2H), 6.95(d, J=8.5Hz, 2H), 5.58(s, 2H), 3.85(m, 3H)

实施例17:1-苄基-4-(1-环己烯基)-1,2,3-三唑的制备  Example 17: Preparation of 1-benzyl-4-(1-cyclohexenyl)-1,2,3-triazole

用116.8mg(1.1mmol)1-环己烯基苯乙炔(II-3)替代苯乙炔,其他操作同实施例1,得到目标产物(I-3)135.5mg,收率为56.60%,白色固体。  116.8mg (1.1mmol) 1-cyclohexenylphenylacetylene (II-3) was used to replace phenylacetylene, and other operations were the same as in Example 1 to obtain 135.5mg of the target product (I-3), with a yield of 56.60%, a white solid . the

1HNMR(CDCl3):δ=7.36-7.40(m,3H),7.30(s,1H),7.30-7.25(m,2H),6.49-6.51(m,1H),5.52(s,2H),2.35-2.38(m,2H),2.17-2.22(m,2H),1.73-1.78(m,2H),1.64-1.69(m,2H).  1 HNMR (CDCl 3 ): δ=7.36-7.40 (m, 3H), 7.30 (s, 1H), 7.30-7.25 (m, 2H), 6.49-6.51 (m, 1H), 5.52 (s, 2H), 2.35-2.38(m, 2H), 2.17-2.22(m, 2H), 1.73-1.78(m, 2H), 1.64-1.69(m, 2H).

实施例18:1-苄基-4-己基-1,2,3-三唑的制备  Example 18: Preparation of 1-benzyl-4-hexyl-1,2,3-triazole

Figure BDA0000134951280000072
Figure BDA0000134951280000072

用121.2mg(1.1mmol)1-辛炔(II-4)替代苯乙炔,其他操作同实施例1,得到目标产物(I-4)222.7mg,收率为91.50%。  121.2 mg (1.1 mmol) of 1-octyne (II-4) was used instead of phenylacetylene, and other operations were the same as in Example 1 to obtain 222.7 mg of the target product (I-4), with a yield of 91.50%. the

1HNMR(CDCl3):δ=7.36-7.38(m,3H),7.25-7.28(m,2H),7.19(s,1H),5.50(s,2H),2.69(t,J=7.8Hz,2H),1.63-1.68(m,2H),1.28-1.35(m,6H),0.88(t,J=6.9Hz,3H)  1 HNMR (CDCl 3 ): δ=7.36-7.38(m, 3H), 7.25-7.28(m, 2H), 7.19(s, 1H), 5.50(s, 2H), 2.69(t, J=7.8Hz, 2H), 1.63-1.68(m, 2H), 1.28-1.35(m, 6H), 0.88(t, J=6.9Hz, 3H)

实施例19:1-苄基-4-对乙氧基苯基-1,2,3-三唑的制备  Example 19: Preparation of 1-benzyl-4-p-ethoxyphenyl-1,2,3-triazole

Figure BDA0000134951280000081
Figure BDA0000134951280000081

用160.8mg(1.1mmol)4-乙氧基苯乙炔(II-5)替代苯乙炔,其他操作同实施例1,得到目标产物(I-5)252.3mg,收率为90.33%,白色固体。  160.8mg (1.1mmol) of 4-ethoxyphenylacetylene (II-5) was used instead of phenylacetylene, and the other operations were the same as in Example 1 to obtain 252.3mg of the target product (I-5) with a yield of 90.33% as a white solid. the

1HNMR(CDCl3):δ=7.71-7.73(m,2H),7.58(s,1H),7.39-7.41(m,3H),7.32-7.7.33(m,2H),6.93-6.94(m,2H),5.58(s,2H),4.07(q,J=7.0Hz,2H),1.44(t,J=7.0Hz,3H).  1 HNMR (CDCl 3 ): δ=7.71-7.73 (m, 2H), 7.58 (s, 1H), 7.39-7.41 (m, 3H), 7.32-7.7.33 (m, 2H), 6.93-6.94 (m , 2H), 5.58(s, 2H), 4.07(q, J=7.0Hz, 2H), 1.44(t, J=7.0Hz, 3H).

实施例20:1-苄基-4-吡啶基-1,2,3-三唑的制备  Example 20: Preparation of 1-benzyl-4-pyridyl-1,2,3-triazole

Figure BDA0000134951280000082
Figure BDA0000134951280000082

用153.5mg(1.1mmol)4-吡啶乙炔盐酸盐(II-6)替代苯乙炔,其他操作同实施例1,得到目标产物(I-6)92.1mg,收率为38.97%,黄绿色固体。  Substitute phenylacetylene with 153.5 mg (1.1 mmol) 4-pyridine acetylene hydrochloride (II-6), and other operations are the same as in Example 1 to obtain 92.1 mg of the target product (I-6), with a yield of 38.97%, a yellow-green solid . the

1HNMR(CDCl3):δ=8.65(d,J=5.8Hz,2H),7.80(s,1H),7.70-7.71(m,2H),7.41-7.44(m,3H),7.33-7.35(m,2H),5.62(s,2H).  1 HNMR (CDCl 3 ): δ=8.65 (d, J=5.8Hz, 2H), 7.80 (s, 1H), 7.70-7.71 (m, 2H), 7.41-7.44 (m, 3H), 7.33-7.35 ( m, 2H), 5.62 (s, 2H).

实施例21:1-苄基-4-苯基-1,2,3-三唑的制备  Example 21: Preparation of 1-benzyl-4-phenyl-1,2,3-triazole

Figure BDA0000134951280000083
Figure BDA0000134951280000083

用126.6mg(1mmol)苄氯(III-2)替代苄溴,其他操作同实施例1,得到目标产物(I -1)221.2mg,收率为94.00%。  126.6 mg (1 mmol) benzyl chloride (III-2) was used to replace benzyl bromide, and other operations were the same as in Example 1 to obtain 221.2 mg of the target product (I-1), with a yield of 94.00%. the

实施例22:1-乙酸乙酯基-4-苯基-1,2,3-三唑的制备  Example 22: Preparation of 1-acetate ethyl-4-phenyl-1,2,3-triazole

Figure BDA0000134951280000091
Figure BDA0000134951280000091

用166.0mg(1mmol)1-溴乙酸乙酯(III-3)替代苄溴,其他操作同实施例1,得到目标产物(I-7)228.2mg,收率为98.80%,白色固体。  166.0 mg (1 mmol) ethyl 1-bromoacetate (III-3) was used instead of benzyl bromide, and the other operations were the same as in Example 1 to obtain 228.2 mg of the target product (I-7) with a yield of 98.80% as a white solid. the

1HNMR(CDCl3):δ=7.93(s,1H),7.86-7.87(m,2H),7.43-7.46(m,2H),7.35-7.38(m,1H),5.22(s,2H),4.31(q,J=7.2Hz,2H),1.33(t,J=7.2Hz,3H).  1 HNMR (CDCl 3 ): δ=7.93 (s, 1H), 7.86-7.87 (m, 2H), 7.43-7.46 (m, 2H), 7.35-7.38 (m, 1H), 5.22 (s, 2H), 4.31(q, J=7.2Hz, 2H), 1.33(t, J=7.2Hz, 3H).

实施例23:1-乙基-4-苯基-1,2,3-三唑的制备  Example 23: Preparation of 1-ethyl-4-phenyl-1,2,3-triazole

用156.0mg(1mmol)碘乙烷(III-4)替代苄溴,其他操作同实施例1,得到目标产物(I-8)137.9mg,收率为79.60%,白色固体。  156.0 mg (1 mmol) ethyl iodide (III-4) was used instead of benzyl bromide, and the other operations were the same as in Example 1 to obtain 137.9 mg of the target product (I-8) with a yield of 79.60% as a white solid. the

1HNMR(CDCl3):7.84-7.86(m,2H),7.78(s,1H),7.42-7.46(m,2H),7.33-7.36(m,1H),4.48(q,J=7.4Hz,2H),1.62(t,J=7.4Hz,3H).  1 HNMR (CDCl 3 ): 7.84-7.86 (m, 2H), 7.78 (s, 1H), 7.42-7.46 (m, 2H), 7.33-7.36 (m, 1H), 4.48 (q, J=7.4Hz, 2H), 1.62(t, J=7.4Hz, 3H).

实施例24:  Example 24:

1-苄基-4-邻苯二甲酰亚胺甲基-1,2,3-三唑  1-Benzyl-4-phthalimidemethyl-1,2,3-triazole

用203.7mg(1.1mmol)邻苯二甲酰亚胺丙炔(II-7)替代苯乙炔,其他操作同实施例1,得到目标产物(I-6)33.1mg,收率为10.4%,白色固体。  Use 203.7mg (1.1mmol) phthalimide propyne (II-7) to replace phenylacetylene, and other operations are the same as in Example 1 to obtain 33.1mg of the target product (I-6), with a yield of 10.4%, white solid. the

1H NMR(CDCl3):δ=7.84(s,1H),7.72-7.81(m,4H),7.14-7.27(m,5H),5.81(s,2H),4.81(s,2H).  1 H NMR (CDCl 3 ): δ=7.84(s, 1H), 7.72-7.81(m, 4H), 7.14-7.27(m, 5H), 5.81(s, 2H), 4.81(s, 2H).

实施例25:  Example 25:

1-苄基-4-对氯苯基-1,2,3-三唑  1-Benzyl-4-p-chlorophenyl-1,2,3-triazole

Figure BDA0000134951280000102
Figure BDA0000134951280000102

用150.2mg(1.1mmol)对氯苯乙炔(II-8)替代苯乙炔,其他操作同实施例1,得到目标产物(I-10)243.6mg,收率为90.3%,白色固体。  150.2mg (1.1mmol) p-chlorophenylacetylene (II-8) was used instead of phenylacetylene, and the other operations were the same as in Example 1 to obtain 243.6mg of the target product (I-10), with a yield of 90.3%, as a white solid. the

1H NMR(CDCl3):δ=7.74-7.76(m,2H),7.66(s,1H),7.33-7.42(m,7H),5.60(s,2H).  1 H NMR (CDCl 3 ): δ=7.74-7.76 (m, 2H), 7.66 (s, 1H), 7.33-7.42 (m, 7H), 5.60 (s, 2H).

实施例26:  Example 26:

1-苄基-4-间氟苯基-1,2,3-三唑  1-Benzyl-4-m-fluorophenyl-1,2,3-triazole

Figure BDA0000134951280000111
Figure BDA0000134951280000111

用132.1mg(1.1mmol)间氟苯乙炔(II-9)替代苯乙炔,其他操作同实施例1,得到目标产物(I-11)221.9mg,收率为87.6%,白色固体。  132.1 mg (1.1 mmol) m-fluorophenylacetylene (II-9) was used instead of phenylacetylene, and the other operations were the same as in Example 1 to obtain 221.9 mg of the target product (I-11), a white solid with a yield of 87.6%. the

1H NMR(CDCl3):δ=7.68(s,1H),7.53-7.58(m,2H),7.32-7.44(m,6H),7.00-7.04(m,1H),5.60(s,2H).  1 H NMR (CDCl 3 ): δ=7.68(s, 1H), 7.53-7.58(m, 2H), 7.32-7.44(m, 6H), 7.00-7.04(m, 1H), 5.60(s, 2H) .

实施例27:  Example 27:

Figure BDA0000134951280000112
Figure BDA0000134951280000112

用137.0mg(1mmol)1-溴代正丁烷(III-5)替代苄溴,其他操作同实施例1,得到目标产物(I-12)58.2mg,收率为28.91%,白色固体。  137.0 mg (1 mmol) of 1-bromobutane (III-5) was used instead of benzyl bromide, and the other operations were the same as in Example 1 to obtain 58.2 mg of the target product (I-12), with a yield of 28.91%, as a white solid. the

1H NMR(CDCl3):δ=7.85-7.87(m,2H),7.77(s,1H),7.43-7.46(m,2H),7.33-7.37(m,1H),4.43(t,J=7.2Hz,2H),1.93-1.99(m,2H),1.38-1.46(m,2H),1.00(t,J=7.5Hz,3H)。 1 H NMR (CDCl 3 ): δ=7.85-7.87(m, 2H), 7.77(s, 1H), 7.43-7.46(m, 2H), 7.33-7.37(m, 1H), 4.43(t, J= 7.2Hz, 2H), 1.93-1.99(m, 2H), 1.38-1.46(m, 2H), 1.00(t, J=7.5Hz, 3H).

Claims (7)

1. the 1H-1 shown in a formula I, 2, the preparation method of 3-triazole class compounds, described preparation method is: the halides shown in formula III is mixed with end-group alkyne compounds and sodiumazide shown in formula II, in reaction solvent under the katalysis of Porous Cu in 25~80 ℃ reaction 5~85h, reaction finish after, reaction solution aftertreatment makes the 1H-1 shown in formula I, 2,3-triazole class compounds; Described solvent is deionized water; The aperture of described Porous Cu is 5~20 μ m;
Figure FDA0000462418430000011
In formula I, formula II or formula III, X is halogen; R 1for C1 to C13 alkyl, benzyl, substituted benzyl or ethyl acetate base, the substituting group on described substituted benzyl phenyl ring is monosubstituted halogen or monosubstituted C1 to C5 alkyl; R 2for C6 to C13 alkyl, 5 yuan to 9 yuan cycloalkenyl groups, phenyl, substituted-phenyl or pyridyl, the substituting group of described substituted-phenyl is monosubstituted C1 to C5 alkoxyl group or monosubstituted halogen.
2. 1H-1 as claimed in claim 1, the preparation method of 2,3-triazole class compounds, is characterized in that: X is Br, Cl or I; R 1for benzyl, C1 to C4 alkyl or ethyl acetate base; R 2for phenyl, p-methoxyphenyl, to ethoxyl phenenyl, rubigan, a fluorophenyl, 4-pyridyl, 1-cyclohexenyl or C6 to C10 alkyl.
3. 1H-1 as claimed in claim 1, the preparation method of 2,3-triazole class compounds, is characterized in that: the aperture of described Porous Cu is 5 μ m.
4. 1H-1 as claimed in claim 1 or 2,2, the preparation method of 3-triazole class compounds, is characterized in that: described halides is 1:1.0~1.2:1.2~2:0.05~0.15 with the ratio of the amount of substance of end-group alkyne compounds, sodiumazide, Porous Cu.
5. 1H-1 as claimed in claim 3,2, the preparation method of 3-triazole class compounds, it is characterized in that: described halides is 1:1.1:2:0.05 with the ratio of the amount of substance of end-group alkyne compounds, sodiumazide, Porous Cu, and the volumetric usage of described reaction solvent is counted 4ml/mmol with the mole number of halides.
6. 1H-1 as claimed in claim 1 or 2, the preparation method of 2,3-triazole class compounds, is characterized in that: temperature of reaction is 55~60 ℃, the reaction times is 8~50h.
7. 1H-1 as claimed in claim 5, the preparation method of 2,3-triazole class compounds, is characterized in that: temperature of reaction is 55~60 ℃, the reaction times is 8~50h.
CN201210029408.2A 2012-02-10 2012-02-10 Preparation method of 1H-1,2,3-triazole compound Active CN102603660B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210029408.2A CN102603660B (en) 2012-02-10 2012-02-10 Preparation method of 1H-1,2,3-triazole compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210029408.2A CN102603660B (en) 2012-02-10 2012-02-10 Preparation method of 1H-1,2,3-triazole compound

Publications (2)

Publication Number Publication Date
CN102603660A CN102603660A (en) 2012-07-25
CN102603660B true CN102603660B (en) 2014-07-02

Family

ID=46521497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210029408.2A Active CN102603660B (en) 2012-02-10 2012-02-10 Preparation method of 1H-1,2,3-triazole compound

Country Status (1)

Country Link
CN (1) CN102603660B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012195B (en) * 2012-12-03 2015-04-22 浙江工业大学 Preparation method of aryl azide compound
CN104119285B (en) * 2013-04-28 2016-06-29 中国科学院广州生物医药与健康研究院 Compound and application thereof as estrogen-related receptor modulator
CN103275022B (en) * 2013-06-08 2015-08-05 浙江工业大学 1-benzyl-1,2,3-triazole compound and its preparation method and application
CN103483279B (en) * 2013-09-10 2015-04-01 浙江大学 Preparation method of 1,4-disubstituted triazole compound
CN103880762B (en) * 2014-04-08 2016-03-16 河南师范大学 A kind of preparation method of 1,2,3-triazole compound
CN105130914B (en) * 2015-09-06 2017-07-11 河南师范大学 A kind of Cu2O‑Al2O3The method for catalyzing and synthesizing 1,2,3 triazole compounds
CN105130916B (en) * 2015-09-30 2019-03-01 江西师范大学 Method for efficiently preparing NH-1,2,3 triazole compound
CN106588788B (en) * 2016-11-11 2019-07-16 河南师范大学 One-pot two-step method for synthesizing 1,2,3-triazoles
CN108912098B (en) * 2018-06-04 2020-04-28 西安交通大学 Pyrimidine compound and application thereof
CN108675988B (en) * 2018-06-04 2020-05-19 西安交通大学 Pyridine compound and application thereof
CN115974847B (en) * 2022-12-16 2024-12-20 中国药科大学 3-(1,2,3-triazol-4-yl)tetrahydroquinazoline-2,4-dione derivatives and their preparation and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005127A2 (en) * 2008-07-09 2010-01-14 Postech Academy-Industry Foundation Heterogeneous copper nanocatalyst and manufacturing methods thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005127A2 (en) * 2008-07-09 2010-01-14 Postech Academy-Industry Foundation Heterogeneous copper nanocatalyst and manufacturing methods thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Click chemistry from organic halides, diazonium salts and anilines in water catalysed by copper nanoparticles on activated carbon;Francisco Alonso et al;《Org. Biomol. Chem.》;20110726;第9卷;6385-6395 *
Unsupported Copper Nanoparticles in the 1,3-Dipolar Cycloaddition of Terminal Alkynes and Azides;Francisco Alonso et al;《Eur. J. Org. Chem.》;20100224;1875-1884 *

Also Published As

Publication number Publication date
CN102603660A (en) 2012-07-25

Similar Documents

Publication Publication Date Title
CN102603660B (en) Preparation method of 1H-1,2,3-triazole compound
CN107382821B (en) A kind of synthetic method of β-iodo-N-alkoxy amine compound
CN107325019B (en) Preparation method of arylaminobenzamide compounds and N-aryl-arylaminobenzamide compounds
CN108794412B (en) Preparation method of 4, 5-diaryl-2H-1, 2, 3-triazole compound
CN111925356A (en) Synthesis and application of chiral quinoline-imidazoline ligands
CN109384789B (en) Synthesis method of indolocazaheptatomic ring catalyzed by monovalent silver
CN103664821B (en) A kind of benzothiazole compound preparation method based near amino thiophenols cyclisation
CN104098518A (en) Preparation method of 1-alkyl-substituted triazole compound
CN103113315A (en) Preparation method of 1-aryl substituted 1H-1, 2, 3-triazole compound
CN108395412A (en) A kind of triazole derivatives and preparation method thereof
CN113045549B (en) Pyrrole ethylene derivative and preparation method thereof
CN102766095B (en) Preparation method of electron-deficient group-containing multi-substituted pyrazole derivative
CN109438439B (en) Tetrahydroisoquinolino 1,2, 4-triazole derivative and preparation method thereof
CN107382769B (en) A kind of preparation method of 1-aryl-3-azido-4,4,4-trifluoro-1-butene compound
CN106588745A (en) Intermediate of benzovindiflupyr and preparation method and application thereof
CN110483379A (en) A kind of preparation method of 1,2,2- triaryl second ketone compounds
CN110981919B (en) Method for synthesizing octatomic amidine cyclic palladium compound by one-pot method and application thereof
CN115572269B (en) N-trifluoroisopropylazole and indole compound and preparation method thereof
CN110038632A (en) A kind of preparation of the lignin different-phase catalyst of sulfonic acid funtionalized and method using the catalyst synthesizing amide class compound
CN111377964B (en) Pyrazole-triazole phosphine compound and application thereof
CN103044313A (en) Method for synthesising carbazole compounds
WO2013027835A1 (en) Method for producing optically active naphthalene compound
CN100491387C (en) Ferrocenyl imidazoline ring palladium compound, its preparation and its application in catalytic synthesis of coupled products
CN107903275B (en) The synthetic method of loop coil 4- hydrogen pyrazole compound
CN105294517A (en) Method for preparing chiral 1, 3-diamine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20191225

Address after: 314000 Waihuan West Road, Jiaxing Port Area, Jiaxing City, Zhejiang Province

Patentee after: JIAXING UNITED CHEMICAL Co.,Ltd.

Address before: 510000 unit 2414-2416, building, No. five, No. 371, Tianhe District, Guangdong, China

Patentee before: GUANGDONG GAOHANG INTELLECTUAL PROPERTY OPERATION Co.,Ltd.

Effective date of registration: 20191225

Address after: 510000 unit 2414-2416, building, No. five, No. 371, Tianhe District, Guangdong, China

Patentee after: GUANGDONG GAOHANG INTELLECTUAL PROPERTY OPERATION Co.,Ltd.

Address before: 310014 Hangzhou city in the lower reaches of the city of Zhejiang Wang Road, No. 18

Patentee before: Zhejiang University of Technology

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210318

Address after: 710061 No.2, floor 6, unit 2, building 4, No.26 Xiying Road, Yanta District, Xi'an City, Shaanxi Province

Patentee after: Liu Mingxin

Address before: 314000 Waihuan West Road, Jiaxing Port Area, Jiaxing City, Zhejiang Province

Patentee before: JIAXING UNITED CHEMICAL Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210909

Address after: 273300 south of the intersection of Wenhua Road and Pingwang Road, Pingyi Economic Development Zone, Pingyi County, Linyi City, Shandong Province

Patentee after: Pingyi ren'an traditional Chinese Medicine Industry Development Co.,Ltd.

Address before: 710061 No.2, floor 6, unit 2, building 4, No.26 Xiying Road, Yanta District, Xi'an City, Shaanxi Province

Patentee before: Liu Mingxin